Skip to main content

People in the News: Sep 5, 2014

NEW YORK (GenomeWeb) – Danaher said this week that it has appointed Thomas Joyce as president and CEO and member of the board of directors. He replaces Lawrence Culp, who will transition to a senior advisory role with the company.

Joyce started his career with Danaher in 1989 as marketing project manager in the company's tool group, and he also has been president of a truck box and storage container manufacturer and a water analytics firm. In 2002, he became a group executive at Danaher, and since 2006 he has been an executive VP with the company, where he has been responsible for Danaher's Life Sciences and Diagnostics and Water Quality businesses.

Culp will continue as an advisor until March 1, 2016.


Roche said this week that Arthur Levinson has resigned from its board of directors, effective immediately. The drugmaker said Levinson, who was chairman and CEO at Genentech from 1999 to 2014, made the decision to avoid any conflict with his post as CEO at Calico, a Google-backed startup.

Levinson has served on Roche's board since 2010. He has been CEO at Calico, which is focused on developing therapies for age-related diseases, since 2013.


Spartan Bioscience announced that Charudutt Shah is its new director of business development, responsible for expanding adoption of Spartan's RX CYP2C19 genotyping system in the US and overseas.

Previously, Shah was at Luminex, where he was global marketing product manager for infectious disease products. He has also been employed at Life Technologies and Toxikon.


The American Society of Human Genetics and the National Human Genome Research Institute have named Katherine Blizinsky an ASHG/NHGRI Genetics and Public Policy Fellow and Elizabeth Tuck a Genetics and Education Fellow. Both fellowships are 16-month appointments.

Blizinsky is a neuroscientist at Northwestern University. She has been studying varying topics in the areas of psychiatric neurogenetics and genomics, gene-environment co-evolution of psychiatric susceptibility, and imaging genetics of neurological and psychiatric conditions. She received the Sage Bionetworks Young Investigator Award in 2012 and co-founded Science Policy Initiative Northwestern, an organization that fosters science policy dialogue in the university community through panel discussions, lectures, and interactive debates.

Tuck has served in various roles related to science education since 2008, including teaching high school biology, developing biotechnology and neuroscience curricula for underserved youth, and organizing science café events for teenagers. She has also conducted laboratory research at the undergraduate and graduate levels, focusing on the genetics and cellular mechanisms underlying neurological diseases.


Progenra has appointed Wayne Hancock to its scientific advisory board.

Hancock is professor of pathology and laboratory medicine at the University of Pennsylvania School of Medicine where he researches immunology, inflammation, and mechanisms of disease pathologies.


Promoted? Changing jobs? GenomeWeb wants to know. [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.
The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.